CTRI/2021/08/035704
尚未招募
未知
To Study the Perception, Effectiveness and Barriers to Providing Care through Teleconsultation Facility at a Tertiary Cancer Centre
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Tata Memorial Hospital
- 状态
- 尚未招募
- 最后更新
- 4年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.The patients would be chosen randomly from the teleconsultation list based the commonly treated cancers in the institute. The patients will berandomly chosen from patients who have taken Teleconsult from this hospital under Adult Hematolymphoid, Breast, Gastrointestinal, Urology, Head and Neck DMGs.
- •2\.Patients who have provided Telephonic Consent
排除标准
- •1\. Patients below the age of 18\.
- •2\. Patients not willing to provide Informed Consent.
结局指标
主要结局
未指定
相似试验
招募中
2 期
Exploring the effectiveness characteristics and preliminary observation of its safety of Huanglian Jiedu Pills in the treatment of excess heat fire-toxicity syndrome: a randomized, double-blind, placebo-controlled, multi-center phase II clinical trialITMCTR1900025326The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
已完成
不适用
Preliminary study for the evaluation of barriers and support factors for the use of robotic systems in intensive care units (Project MobiStaR)Evaluation of barriers and support factors for the use of robotic systems in intensive care unitsDRKS00023848MU Klinikum40
终止
不适用
ow-cost, at home cooling strategies for older adults during hot-and-humid heatwaves.ACTRN12618001913268niversity of Sydney32
终止
不适用
ow-cost, at home cooling strategies for older adults during hot-and-dry heatwavesHeat related cardiovascular strainThermal perception (comfort and sensation)Sweating impairmentsThermoregulatory strainHeat-related cognitive declineInjuries and Accidents - Other injuries and accidentsPublic Health - Other public healthCardiovascular - Normal development and function of the cardiovascular systemACTRN12619000938101niversity of Sydney20
进行中（未招募）
不适用
Dose ranging study of glycopyrronium bromide in moderate/severe COPDEUCTR2012-003791-40-GBProsonix Limited